FTA and PBS – the US view
For those who think the Free Trade Agreement will do no harm to the Pharmaceutical Benefits Scheme, it’s worth reading this NYT piece, which focuses on impacts in the US>.
By the way, although we may pay more for medicine, we are the way to a cure for the dread affliction of linkrot. The NYT has provided weblog-safe links using its RSS feed. Thanks to Jack Strocchi for alerting me to this.